Novatio Ventures is a venture capital firm accelerating the commercialization of life science innovations.The firm's focus is on the development of innovations and other markets that represents a significant source of opportunities for outsized value creation. It invests in firms operating in therapeutics, diagnostics, devices, and drug delivery technologies. They target early-stage innovation on the transition of preclinical proof-of-concept or validation and provides seed funding and work actively with inventors, entrepreneurs, and institutions to devise and implement development and commercialization strategies, assemble management teams, and secure additional capital. It aims to leverage their collective experience and industry network to achieve early exits that generate attractive, risk-mitigated financial returns.